| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1009218157 |
| P356 | DOI | 10.1186/1477-7819-8-111 |
| P932 | PMC publication ID | 3016250 |
| P698 | PubMed publication ID | 21176227 |
| P5875 | ResearchGate publication ID | 49700487 |
| P2093 | author name string | Michael Stamatakos | |
| Konstantinos Kontzoglou | |||
| Konstantinos Xiromeritis | |||
| Ioannis Pateras | |||
| Ioannis Alexiou | |||
| Ioannis Karaiskos | |||
| Victoria Palla | |||
| P2860 | cites work | Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription | Q24290273 |
| Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation | Q24544755 | ||
| Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 | Q24644847 | ||
| Activation of human B-MYB by cyclins | Q24674836 | ||
| Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) | Q24685138 | ||
| The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines | Q25254998 | ||
| Cyclin E and survival in patients with breast cancer | Q27824788 | ||
| Cycling to cancer with cyclin D1 | Q28214862 | ||
| Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment | Q28235209 | ||
| Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway | Q28237113 | ||
| Minireview: Cyclin D1: normal and abnormal functions | Q28279069 | ||
| Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3) | Q28298777 | ||
| Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes | Q33699243 | ||
| Anticancer drug targets: cell cycle and checkpoint control. | Q33801116 | ||
| Novel splice variants of cyclin E with altered substrate specificity | Q33855990 | ||
| Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms | Q33969505 | ||
| Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. | Q34760368 | ||
| Cyclin D1 determines mitochondrial function in vivo | Q35070938 | ||
| Cyclin D1, EMS1 and 11q13 amplification in breast cancer | Q35130688 | ||
| Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. | Q53395603 | ||
| Cyclin Dl expression in B-cell non Hodgkin lymphoma. | Q53543241 | ||
| Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma | Q63633957 | ||
| Conserved structural motifs in cyclins identified by sequence analysis | Q67904096 | ||
| Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein | Q71672628 | ||
| Cyclin E, a potential prognostic marker for breast cancer | Q72662855 | ||
| Expression and amplification of cyclin genes in human breast cancer | Q72845253 | ||
| Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status | Q73982407 | ||
| Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression | Q74029730 | ||
| Expression of cell cycle regulators in human cutaneous malignant melanoma | Q77919021 | ||
| Cycling without cyclins. | Q35601085 | ||
| Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas | Q35842080 | ||
| Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity | Q35888709 | ||
| Redundant cyclin overexpression and gene amplification in breast cancer cells | Q36090819 | ||
| Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review | Q36147654 | ||
| Do truncated cyclins contribute to aberrant cyclin expression in cancer? | Q36427775 | ||
| Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression | Q36759552 | ||
| Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma | Q36851904 | ||
| Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression | Q37215894 | ||
| Cancer therapy: targeting cell cycle regulators | Q37294018 | ||
| Nuclear cyclin D1: an oncogenic driver in human cancer | Q37470373 | ||
| Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells | Q39736048 | ||
| Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy | Q39882401 | ||
| Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. | Q39946549 | ||
| Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization | Q40245226 | ||
| The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. | Q40459704 | ||
| Cyclin E deregulation alters the biologic properties of ovarian cancer cells. | Q40580984 | ||
| Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis | Q40612363 | ||
| HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin | Q41045815 | ||
| Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. | Q41163429 | ||
| Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators | Q41450893 | ||
| The role of cyclin E in cell proliferation, development and cancer | Q41744187 | ||
| Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas | Q42804103 | ||
| The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein | Q42811919 | ||
| Cyclin D1 expression in typical chronic lymphocytic leukaemia | Q47731697 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cell cycle | Q188941 |
| neoplasm | Q1216998 | ||
| Cyclin E | Q24724860 | ||
| Cyclin D | Q24781041 | ||
| cell cycle proteins | Q76598519 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 111 | |
| P577 | publication date | 2010-12-22 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Cell cyclins: triggering elements of cancer or not? | |
| P478 | volume | 8 |
| Q53079443 | A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19. |
| Q38064457 | Cell cycle-related kinase in carcinogenesis |
| Q57817291 | Clinical significance and biological roles of cyclins in gastric cancer |
| Q34083001 | Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes. |
| Q35151182 | Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies. |
| Q35843010 | Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds |
| Q39206919 | Effects of cyclin E gene silencing on the proliferation of esophageal cancer cell lines, EC9706, Eca109 and KYSE30. |
| Q41840776 | Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique |
| Q36475933 | Expression of cyclin E in stage III colorectal carcinoma |
| Q36823677 | Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone |
| Q35686653 | High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7 |
| Q50722957 | High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma. |
| Q37982050 | Human gene control by vital oncogenes: revisiting a theoretical model and its implications for targeted cancer therapy |
| Q60912152 | Immunohistochemical analysis of cyclin A expression in Wilms tumor |
| Q38994765 | Implant of polymer containing pentacyclic triterpenes from Eugenia punicifolia inhibits inflammation and activates skeletal muscle remodeling. |
| Q37584898 | Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer. |
| Q38287178 | MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition. |
| Q36838387 | Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period |
| Q61445018 | Nonylphenol promotes the proliferation of colorectal cancer COLO205 cells by upregulating the expression of protein kinase C ζ |
| Q37336665 | Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE. |
| Q33782164 | PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation |
| Q38949849 | Sterigmatocystin induces G1 arrest in primary human esophageal epithelial cells but induces G2 arrest in immortalized cells: key mechanistic differences in these two models |
| Q27025081 | The function and molecular mechnism of cyclin Y protein |
| Q50752830 | The prognostic value of cyclin D1 in renal cell carcinoma. |
| Q38205270 | The role of the TP73 gene and its transcripts in neuro-oncology |
| Q36025441 | Tumor suppressor functions of FBW7 in cancer development and progression |
Search more.